Dimeric IgA (dIgA) engineered to target mutated cytoplasmic oncodrivers abrogates tumor growth. ©2023 American Association for Cancer Research.
Intracellular Oncoproteins Can Be Targeted by Mutation-Specific Dimeric IgA. Cancer discovery. 2024 Jan 12;14(1):14
PMID: 37975652
View Full Text